Biotech Values

[DewDiligence]

ICPT submits NDA for Ocaliva/25mg in NASH:

https://www.globenewswire.com/news-release/2019/09/27/1922072/0/en/Intercept-Submits-New-Drug-Application-to-the-U-S-FDA-for-Obeticholic-Acid-in-Patients-with-Fibrosis-Due-to-NASH.html